Chihiro Morishima

InstitutionUniversity of Washington
AddressSeattle
Washington
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 2 publications in July 2020 and November 2020 and August 2021
    All Publications
    Bar chart showing 55 publications over 17 distinct years, with a maximum of 6 publications in 2006 and 2009
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hendelman T, Chaudhary A, LeClair AC, van Leuven K, Chee J, Fink SL, Welch EJ, Berthier E, Quist BA, Wald A, Wener MH, Hoofnagle AN, Morishima C. Self-collection of capillary blood using Tasso-SST devices for Anti-SARS-CoV-2 IgG antibody testing. PLoS One. 2021; 16(9):e0255841. PMID: 34473717.
      Citations:    Fields:    Translation:HumansPHPublic Health
    2. Bradley BT, Bryan A, Fink SL, Goecker EA, Roychoudhury P, Huang ML, Zhu H, Chaudhary A, Madarampalli B, Lu JYC, Strand K, Whimbey E, Bryson-Cahn C, Schippers A, Mani NS, Pepper G, Jerome KR, Morishima C, Coombs RW, Wener M, Cohen S, Greninger AL. Anti-SARS-CoV-2 Antibody Levels Measured by the AdviseDx SARS-CoV-2 Assay Are Concordant with Previously Available Serologic Assays but Are Not Fully Predictive of Sterilizing Immunity. J Clin Microbiol. 2021 08 18; 59(9):e0098921. PMID: 34165323.
      Citations: 4     Fields:    Translation:Humans
    3. Chung SH, Wener M, Bays AM, Rahbar H, Morishima C, Bryan AB, Fink SL, Cohen S, Mani NS, Chaudhary A, Gardner GC. Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli et al. Ann Rheum Dis. 2021 10; 80(10):e165. PMID: 34340981.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    4. Boonyaratanakornkit J, Morishima C, Selke S, Zamora D, McGuffin S, Shapiro AE, Campbell VL, McClurkan CL, Jing L, Gross R, Liang J, Postnikova E, Mazur S, Lukin VV, Chaudhary A, Das MK, Fink SL, Bryan A, Greninger AL, Jerome KR, Holbrook MR, Gernsheimer TB, Wener MH, Wald A, Koelle DM. Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates. J Clin Invest. 2021 02 01; 131(3). PMID: 33320842.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    5. Lerma LA, Chaudhary A, Bryan A, Morishima C, Wener MH, Fink SL. Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19). J Transl Autoimmun. 2020; 3:100073. PMID: 33263103.
      Citations: 15     
    6. Bryan A, Fink SL, Gattuso MA, Pepper G, Chaudhary A, Wener MH, Morishima C, Jerome KR, Mathias PC, Greninger AL. SARS-CoV-2 Viral Load on Admission Is Associated With 30-Day Mortality. Open Forum Infect Dis. 2020 Dec; 7(12):ofaa535. PMID: 33349793.
      Citations: 12     
    7. Das MK, Chaudhary A, Bryan A, Wener MH, Fink SL, Morishima C. Rapid Screening Evaluation of SARS-CoV-2 IgG Assays Using Z-Scores to Standardize Results. Emerg Infect Dis. 2020 10; 26(10):2501-2503. PMID: 32723430.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    8. Bryan A, Pepper G, Wener MH, Fink SL, Morishima C, Chaudhary A, Jerome KR, Mathias PC, Greninger AL. Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho. J Clin Microbiol. 2020 07 23; 58(8). PMID: 32381641.
      Citations: 233     Fields:    Translation:HumansCellsPHPublic Health
    9. Burbelo PD, Riedo FX, Morishima C, Rawlings S, Smith D, Das S, Strich JR, Chertow DS, Davey RT, Cohen JI. Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019. J Infect Dis. 2020 06 29; 222(2):206-213. PMID: 32427334.
      Citations: 98     Fields:    Translation:HumansCellsPHPublic Health